Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enyo Pharma
Biotech
Enyo Pharma notches a mid-stage trial win in tricky NASH
Enyo Pharma’s liver disease drug reduced liver fat and boosted kidney health during a mid-stage clinical trial.
Annalee Armstrong
Jul 28, 2021 10:18am
Metacrine raises $65M to kick off NASH clinical testing
Jun 6, 2018 9:51am
Enyo raises $47M to bring hep B, NASH drug to phase 2
Jun 4, 2018 10:18am
Charles River’s target identification tech helps Enyo Pharma
Nov 29, 2017 8:01am
